Related Experiment Video

Updated: Aug 17, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

[Effects of MAPK antagonist on TPO stimulated UT2 cells proliferation and differentiation]

Wen-lin Li1, Xiao-yu Shi, Rong Li

  • 1Jiangxi Key Laboratory of Medical Biology, Jiangxi Medical Science Institute, Nanchang 330006, China.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|June 14, 2005
PubMed
Abstract

Insights

Thrombopoietin (TPO) stimulates UT7 cell proliferation and differentiation via the MAPK pathway. Inhibiting MEK1 phosphorylation with PD98059 or a mutant MEK1 gene blocks TPO

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • Thrombopoietin (TPO) is a key regulator of megakaryopoiesis.
  • UT7 cells are a human megakaryoblastic leukemia cell line responsive to TPO.
  • The Mitogen-Activated Protein Kinase (MAPK) pathway plays a crucial role in cell proliferation and differentiation.

Purpose of the Study:

  • To investigate the role of the MAPK pathway in TPO-mediated effects on UT7 cells.
  • To determine how MAPK antagonists affect UT7 cell proliferation and differentiation.
  • To elucidate the mechanism of TPO signaling in UT7 cells.

Main Methods:

  • UT7 cells were transfected with MEK1 plasmids (wild-type and mutant).
  • MAPK pathway activation was assessed by Western blot for phosphorylated MEK1.
  • Cell proliferation and CD41 expression (a megakaryocyte marker) were measured after TPO stimulation and MAPK inhibition.

Main Results:

  • TPO stimulation induced MEK1 phosphorylation in UT7 cells in a time-dependent manner.
  • Inhibition of MEK1 phosphorylation using PD98059 or a mutant MEK1 gene significantly reduced TPO-induced UT7 cell proliferation.
  • TPO-induced CD41 expression was also inhibited by MEK1 phosphorylation blockade.

Conclusions:

  • TPO signaling in UT7 cells involves the phosphorylation of MEK1.
  • The MAPK signal transduction pathway is essential for TPO's effects on UT7 cell proliferation and CD41 expression.
  • Targeting the MAPK pathway offers a potential strategy to modulate TPO-driven cellular responses.

More Related Videos

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...